主会场(5月18日上午) | ||
7:30-8:30 | 报到 | |
时间 Time | 内容 Content | 讲者/单位 Speaker/ Institution |
8:30-8:40 | Opening remark 致辞 | 大会主席 Chairman of the conference 马洁 Jie Ma 北京医院 Beijing Hospital Hongtao Liu 刘洪涛 Assistant Professor of Medicine Section of Hematology / Oncology Chicago University 芝加哥大学血液肿瘤科 |
8:40-9:10 | Haploidentical transplantation: some concept, different results 单倍体移植:一些观点和不同结果 | 黄晓军 XiaoJun Huang 北京大学血液病研究所所长、北京大学人民医院血液科主任Chairman, Peking University Institute of Hematology、 Director, Department of Hematology, Peking University People’s Hospital |
9:10-9:40 | the past, current and the future of stem cell transplant and cellular therapy 干细胞移植和细胞的过去,现在和将来 | Dr. Michael Bishop Professor of Medicine Section of Hematology / Oncology Chicago University 芝加哥大学血液肿瘤科 |
9:40-10:10 | State-of-the art of treatment of ALL: molecular, antibody and cellular targeting to eradicate MRD ALL新技术:分子,抗体和细胞靶向MRD | Dr. Wendy Stock Professor of Medicine Chicago University 芝加哥大学 |
10:10-10:30 | 讨论Discussion | |
10:30-10:40 | 茶歇 Tea break | |
10:40-11:10 | 肾细胞癌的免疫 Immunotherapy for renal cell carcinoma | 龚侃 Kan Gong 北京大学第一医院 Peking University First Hospital |
11:10-11:40 | 实体肿瘤细胞临床研究 Clinical study in cellular immunotherapy for solid tumors | 马洁 Jie Ma 北京医院 Beijing Hospital |
11:40-12:10 | 前列腺癌免疫进展 Progress in immunotherapy for prostate cancer | 王伟 Wei Wang 北京同仁医院 Beijing Tongren Hospital |
Hematology血液学分会场(5月18日下午) (免费参会) | ||
时间 Time | 内容 Content | 讲者/单位 Speaker/ Institution |
13:30-13:40 | Opening remark 致辞 | |
13:40-14:10 | Donor-derived HCMV-specific T cells therapy for CMV infection post allogenic stem cell 造血干细胞移植后供者来源HCMV特 异性T细胞巨细胞病毒感染 | Dr. Xiangyu Zhao 赵翔宇 Section of hematology/Peking University Institute of Hematology 智能营销客户管理系统北京大学人民医院血液科、北京大学血液病研究所 |
14:10-14:40 | Road to improve the outcomes of AML with poor gene mutation-experience from a single center 如何提高不良基因突变的AML预后 | Dr. Daihong Liu 生物厕所刘代红 Section of Hematology PLA First medical center (PLA 301 Hospital) 解放军总医院第一医学中心血液科 |
14:40-15:10 | Discussion讨论 | |
15:10-15:30 | Tea break 茶歇 | |
15:30-16:30 | Immunotherapies in Hematologic malignancies 血液肿瘤的免疫 | Dr. Hongtao Liu 刘洪涛 Assistant Professor of Medicine Section of Hematology / Oncology Chicago University 芝加哥大学血液肿瘤科 |
16:00-16:30 | CD19CAR-T for treatment of B cell ALL Chinese experience CD19CAR-T细胞B-ALL的中国经验 | Dr. Peihua Lu 陆佩华 Hematology of Lu Daopei Hospital 陆道培医院,血液.肿瘤科 |
16:30-17:00 | The CART treatment for lymphomas 淋巴瘤的CAR-T | Dr. Peter Riedell Assistant Professor of Medicine 中波塔Section of Hematology / Oncology Chicago University 芝加哥大学血液肿瘤科 |
17:00-17:30 | Discussion 讨论 | |
Urology泌尿肿瘤分会场(5月18日下午) (免费参会) | ||
时间 Time | 内容 Content | 讲者/单位 Speaker/ Institution |
13:30-13:40 | 致辞 Address | 龚侃 Kan Gong 北京大学第一医院 Peking University First Hospital |
第一部分 Part one | 主持嘉宾:李宏召 卢剑 毕新刚 Guest host: Hongzhao Li, Zheng li, Xingang Bi | |
13:40-14:10 | 泌尿系肿瘤免疫经验分享 Experience in immunotherapy of urinary tumors | 麦海星 Haixing Mai 解放军第五医学中心(原307医院) PLA Fifth medical center (PLA 307 Hospital) |
14:10-14:40 | PSMA-PET在前列腺癌诊疗中的应用 Application of PSMA-PET in the diagnosis and treatment of prostate cancer | 张宁 Ning Zhang 北京大学肿瘤医院 Beijing Cancer Hospital, Peking University |
14:40-15:10 | 讨论嘉宾:王伟 范欣荣 赵国华 蔡林 Discussion: Wei Wang, Xinrong Fan, Guohua Zhao, Lin Cai | |
15:10-15:30 | 茶歇Tea break | |
第二部分 Part two | 媒体播放主持嘉宾:张勇 张争 王建伟 Guest host: Yong Zhang, Jian Lu, Jianwei Wang | |
15:30-16:00 | 尿路上皮癌免疫的应用 Application of immunotherapy for urothelial carcinoma | 郝钢跃 Gangyue Hao 北京友谊医院 Beijing Friendship Hospital |
16:00-16:30 | 免疫不良反应的处理 Management of adverse immune reactions | 范欣荣 Xinrong Fan 北京协和医院 Peking Union Medical College Hospital |
16:30-17:00 | 讨论嘉宾:毕新刚 麦海星 杨奕 吴鹏杰 Discussion: Xingang Bi, Haixing Mai, Yi Yang, Pengjie Wu | |
17:00-17:30 | 总结 Conclusion | 李宏召 解放军第一医学中心 Hongzhao Li PLA first medical center (PLA 301 Hospital) |
日程管理 |
临床管理培训会分会场(5月18日下午) (注册参会) | |||
时间 Time | 内容 Content | 讲者/单位 Speaker/ Institution | |
13:30-13:40 | 致辞 Address | ||
13:40-14:25 | 肿瘤细胞免疫的原理与设计 Principles and design of Cellular Immunotherapy of Cancer | 韩为东Weidong Han 解放军总医院第一医学中心 PLA First medical center (PLA 301 Hospital) | |
14:25-15:10 | 细胞临床实验设计 Clinical trial design for cellular therapy | 张毅 Yi Zhang 郑州大学第一附属医院 The First Affiliated Hospital of Zhengzhou University | |
15:10-15:20 | 茶歇Tea break | ||
15:20-16:05 | 实体瘤免疫思考与实践 Thinking and practice of solid tumor immunotherapy | 崔久巍 Jiuwei Cui 吉林大学第一附属医院 The First Affiliated Hospital of Jilin University | |
16:05-16:50 | 临床试验过程控制及常见问题 Process control and common problems in clinical trials | 北京医院 Beijing Hospital | |
16:50-17:35 | Choosing Gene Therapy Clinical Trial Candidates: getting from gene selection to the bedside. 选择基因临床试验受试者:从基因选择到临床试验 | Martin E Jaysson Apexell Medicine | |
临床管理培训会分会场(5月19日上午) | |||
时间 Time | 射频调制器内容 Content | 讲者/单位 Speaker/ Institution | |
8:30-8:40 | 致辞 Address | ||
8:40-9:30 | 细胞产业国家政策及分析 National policy and analysis of cellular therapy industry | 国家卫生健康委 The National Health Commission | |
9:30-10:20 | 细胞药物审评技术要求 Technical requirements for cellular drug evaluation | 国家药品监督管理局药品审评中心 Drug Evaluation Center of the State Food and Drug Administration | |
10:20-11:10 | CAR-T细胞药物监管法规与质量控制 Regulations and quality control of Car-T cell therapeutic drugs | 中国食品药品检定研究院 生物制品检定所 Institute of Biological Products Inspection, China Academy of Food and Drug Inspection | |
11:10-12:00 | 利用免疫力评估指导肿瘤免疫细胞 Tumor immunotherapy guided by immune assessment | 张志新 Zhixin Zhang 四川大学华西第二医院 The West China Second University Hospital of Sichuan University (WCSUH- SCU) | |
本文发布于:2024-09-22 07:38:33,感谢您对本站的认可!
本文链接:https://www.17tex.com/tex/4/346255.html
版权声明:本站内容均来自互联网,仅供演示用,请勿用于商业和其他非法用途。如果侵犯了您的权益请与我们联系,我们将在24小时内删除。
留言与评论(共有 0 条评论) |